Skip to content
Tenfell
Upcoming
Published 27 Mar 2018

Antenatal Sickle Cell and Thalassaemia and/or Glycated Haemoglobin Measurement (Laboratory/Clinic Based) Including Newborn Sickle Cell Screening Equipment, Reagents and Associated Products

NHS Supply Chain · United Kingdom

Key facts

Estimated value
£14,000,000
Contract starts
16 Jan 2019
Contract ends
15 Jan 2023
Procedure
Open procedure (above threshold)
Buyer type
Health

Description

The Framework will consist of reagent rental and/or purchases of analysers and reagents capable of accommodating tests for the screening of both Antenatal Sickle Cell and Thalassaemia and the measurement of Glycated Haemoglobin. Also for analysers and reagents capable of accommodating tests for the measurement of Glycated Haemoglobin only and Newborn Sickle Cell screening equipment, including analyser(s), reagents and associated products. The requirement is for an automated system offering detection of Sickle Cell Haemoglobin and other common Haemoglobin variants, using eluates from the newborn bloodspot card in those laboratories undertaking newborn bloodspot screening.

Categories (CPV)

Similar open tenders

About NHS Supply Chain

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.